Results for tag: "Desmoid Tumor Drug"

The Desmoid Tumor Drug market is a subset of the Oncology Drugs market. Desmoid tumors are rare, non-cancerous tumors that can occur in the abdomen, chest, or other parts of the body. Treatment for desmoid tumors typically involves surgery, radiation therapy, and chemotherapy. However, there are also a number of drugs available to treat desmoid tumors, including non-steroidal anti-inflammatory drugs (NSAIDs), hormonal therapies, and targeted therapies. The Desmoid Tumor Drug market is a relatively small market, but it is growing as more treatments become available. The market is expected to benefit from the development of new drugs and the increasing awareness of desmoid tumors. Some companies in the Desmoid Tumor Drug market include Pfizer, Novartis, Merck, and Bristol-Myers Squibb. Show Less Read more